Biggest News Aggregation in the World
📰 Exceptional Items News

Page 2 - Exceptional Items News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Exceptional Items. Real-time updates on events, politics, business and more.

Sun Pharma's growth prospects look healthy; analysts positive on the stock

Sun Pharmaceutical Industries (Sun Pharma) reported a turnaround in the January-March quarter of the 2022-23 financial year (Q4FY23), declaring a profit after tax (PAT) of Rs 1,984 crore versus a loss of Rs 2,277 crore in Q4FY22. However, that loss in FY22 was due to several exceptional one-time items -- with Rs 3,723.15 crore allocated to settlement of lawsuits in the US and other Exceptional Items adding up to Rs 3,935.75 crore. Adjusted for exceptional items, PAT in Q4FY22 amounts to Rs 2,155...
Sun Pharma Sun Pharmaceutical Industries Pharma Sun Pharmaceutical Industries Exceptional Items Employee Costs Adjusted Revenue
Source: rediff.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

India News | Railtel Posts Its Highest Ever Operating Income of Rs. 1964 Crores in FY 2022-23

Get latest articles and stories on India at LatestLY. The Company has posted annual growth of 27 per cent in revenue, with Total Consolidated Operating Revenue at Rs. 1964 Crores as against Previous Year corresponding figure of Rs.1548 crores. The Company has achieved an EBITDA margin of 20 per cent in Q4 in comparison to Q3 of 17 per cent. India News | Railtel Posts Its Highest Ever Operating Income of Rs. 1964 Crores in FY 2022-23.
New Delhi India General Sanjai Kumar Ministry Of Jal Shakti Consolidated Operating Income Total Consolidated Operating Revenue

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science